Conavi Medical (@ConaviMed) header
Conavi Medical (@ConaviMed) profile picture

Disrupting #ImageFirst with Novasight Hybrid, the first intracoronary imaging system combining co-registered #IVUS and #OCT $CNVI.V $CNVIF

Toronto, ON
Joined April 2021
Photo by Conavi Medical (@ConaviMed)Photo by Conavi Medical (@ConaviMed)Photo by Conavi Medical (@ConaviMed)Photo by Conavi Medical (@ConaviMed)Photo by Conavi Medical (@ConaviMed)Photo by Conavi Medical (@ConaviMed)Photo by Conavi Medical (@ConaviMed)Photo by Conavi Medical (@ConaviMed)Photo by Conavi Medical (@ConaviMed)Photo by Conavi Medical (@ConaviMed)
$CNVI.V $CNVIF When doctors in the lab tell you a catheter delivers like butter and positively compares your product to the legacy technologies they use, that’s the feedback that matters most. During a recent catch-up chat with @RadiusResearch, our CEO @ThomasLooby shared a comprehensive update on #Conavi, from clearance, to capital raised, to the 13 human cases completed with #OCTIV ahead of #TCT2026. Watch it here ▶️ youtube.com/watch?v=1lSdM5oW…
1
1
4
920
$CNVI.V $CNVIF Big moment with Dr. Khady Fall, pictured with our team, marking an important milestone for #Conavi: the first U.S. commercial placement and clinical cases of #OCTIV™. Thank you to our incredible team, physicians, partners, and investors who have all shared in our vision. We're excited for what's ahead as we continue to advance our next-gen hybrid imaging system through commercial rollout. 🫀
1
7
514
$CNVI.V $CNVIF Last day to catch #Conavi at #TCT2026! 🫀 It’s been action-packed days of OCTIV™ demos and valuable conversations with KOLs and innovators in #InterventionalCardiology. Swing by our booth # 4026 before the show wraps up to connect with our team, and don’t miss this morning’s seminars in the Imaging Pavilion at 8:00 AM and 10:00 AM PT. 🕙
2
5
506
$CNVI.V $CNVIF #Conavi Milestone: First U.S. placement and clinical cases complete for our FDA-cleared, next-generation hybrid #IVUS-#OCT imaging system. The commercial name OCTIV™, powered by Novasight™, was inspired by the musical term “octave,” reflecting two complementary imaging modalities working in harmony to guide coronary interventions. Dr. Megha Prasad and fellow physicians performed the first cases, marking the start of #OCTIV’s U.S. commercial rollout ahead of our participation in #TCT2026. Full Release 🔗 lnkd.in/gpAGzivY
1
3
191
$CNVI.V $CNVIF #TCT2026 is almost here, and as CEO @ThomasLooby shared: “This year’s TCT marks an important step for Conavi as we showcase our next-generation system following FDA clearance, giving physicians IVUS and OCT imaging simultaneously in a single pullback… We look forward to introducing physicians to our cleared system and building relationships with potential clinical users as we advance our U.S. commercialization.” See below for where you can connect with #CNVI and come by our booth 📍 4026 in the Main Aisle! More details on @TCTConference here 🔗 lnkd.in/g5Tu2U3f
2
211
$CNVI.V $CNVIF Every step taken toward clearer insights helps to save lives. At #Conavi, that is what drives us. 🫀 This #WorldHeartDay, we stand with the @worldheartfed in support of #DontMissABeat, a global push for greater awareness, early detection, and timely action when it comes to #HeartHealth. 🩺 Cardiovascular disease remains the world’s leading cause of death, making every diagnostic insight and treatment decision critical.
1
136
$CNVI.V $CNVIF Two imaging modalities, complementary insights to guide clinical decisions. 🩺 A @ccijournal case report shows the value of #Conavi's hybrid imaging system during a complex coronary procedure, allowing physicians to use: ➡️ #IVUS: vessel sizing and plaque assessment ➡️ #OCT: higher resolution to characterize the extent and depth of the dissections ➡️ Together: helped physicians identify proximal and distal edge dissections, as well as white thrombus, following stent placement 🔗 lnkd.in/gxH6uaqp
1
1
3
1,553
$CNVI.V $CNVIF #Conavi is pleased to share a new peer-reviewed case report published in Catheterization and Cardiovascular Interventions, demonstrating the clinical utility of our hybrid #IVUS-#OCT system. We also announced that Aman Thind, Co-Founder and CTO, is taking on leadership of R&D. #CNVI Press Release 🔗 lnkd.in/g5e-x5s7 @ccijournal publication 📋 lnkd.in/gxH6uaqp
5
643
$CNVI.V $CNVIF #Conavi is pleased to announce the successful closing of its $10 million public offering! Thank you to Bloom Burton and the syndicate of agents for leading this transaction, as well as our new and existing investors for the strong support and confidence in #CNVI as we advance this next stage of our growth. Full Press Release 🔗 lnkd.in/grMVGdEb
1
1
577
$CNVI.V $CNVIF @SCAI New publication in @MyJSCAI titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules,” demonstrates how complementary #IVUS and #OCT information supports lesion assessment, treatment planning, and stent optimization while helping manage contrast use. Following recent U.S. FDA #510k clearance, this publication featuring #Conavi's hybrid system further strengthens the clinical evidence supporting our upcoming commercial rollout. 🔗 Full Release: lnkd.in/gt-CwHds 🔗 Publication: lnkd.in/gMr_CJT5
1
5
2,448
$CNVI.V $CNVIF #Conavi has entered into an agreement with the Province of Ontario as part of the Life Sciences Scale-Up Fund (#LSSUF) to support the commercial launch of our next-gen #NovasightHybrid™ system!🫀 We appreciate the @ONeconomy and @VictorFedeli for advancing innovation in #LifeSciences and #MedTech. 🔗 Read the full #CNVI release: lnkd.in/erfG2GX
1
1
3
355
$CNVI.V $CNVIF Life Sciences Scale-Up Fund milestone hit for #Conavi! Triggered by our recent U.S. FDA #510k clearance, proceeds will support our hybrid #IVUS-#OCT imaging system across: ☑️ Commercialization initiatives ☑️ Manufacturing scale-up activities ☑️ Project costs associated with the U.S. market launch Thank you @ONeconomy and @VictorFedeli for your continued partnership! Full #CNVI PR 🔗 lnkd.in/gbmXuwpY
1
2
4
896
$CNVI.V $CNVIF This quarter, #Conavi received the 'Best New Technology Solution– Imaging' Award for its next-generation hybrid #IVUS-#OCT imaging platform. 🫀 Thank you @MedTech_Awards for this recognition! More details 🔗 medtechbreakthrough.com/2026… #MedTech #IntravascularImaging #HealthcareInnovation
1
1
3
1,960
New @MyJSCAI publication analyzed 25 studies across multiple countries... When evaluated over a patient’s lifetime, #IntravascularImaging not only improves outcomes significantly, but is cost-effective and often cost-saving, reducing adverse events and repeat interventions. Increases number of #PCI procedures, clinical evidence, guideline support, and adoption of IVI, understanding its long-term economic impact has become increasingly important. Read more on the publication here 🔗 lnkd.in/etsiwkGD $CNVI.V $CNVIF @SCAI #Conavi
1
1
4
1,676
$CNVI.V $CNVIF From CEO @ThomasLooby: "Fiscal Q2 2026 marked a transformational period for #Conavi highlighted by FDA #510k clearance of our next-generation hybrid #IVUS-#OCT imaging system, a milestone that positions the Company for commercial launch in the U.S..." Read more 🔗 lnkd.in/ecbEGaVP
1
2
1,994
$CNVI.V $CNVIF #Conavi CEO @ThomasLooby sat down with @RadiusResearch to discuss everything surrounding our next-generation imaging system and recent U.S. #FDA 510(k) clearance! ☑️ Watch the full video here 🔗 lnkd.in/e2NaZZF4 #CNVI #IntravascularImaging #510k #CEOInterview
📋 @ConaviMed (TSXV: $CNVI | OTCQB: $CNVIF) – FDA Clearance Update CEO Thomas Looby reviews the recent FDA clearance of #ConaviMedicals's next-generation hybrid #intravascularimaging system and discusses what the milestone means for the company's position in the #cardiovascularimaging market. ▶️ Watch the full interview here ➝ youtu.be/1BpJ2eWAJQk #MedTech #MedicalDevices #HealthcareInnovation
1
388
$CNVI.V $CNVIF ▶️ In case you missed it: #TBT to the #BBHIC2026 last week! 1st #Conavi presentation after receiving U.S. FDA #510k clearance on our next-generation hybrid imaging system. 🔗 Watch it here: lnkd.in/er6QQMfi
156
$CNVI.V $CNVIF Exciting week! 🫀 ☑️U.S. FDA #510k Clearance ☑️ Productive time at #BBHIC2026 ☑️#TagAward Recipient 🔗 lnkd.in/eN6CNmQB As #Conavi CEO Tom Looby expressed: "We are honoured to receive this recognition from TAG at such an important moment for Conavi, this award reflects the strength of our technology and the dedication of our team. With the recent FDA clearance of our next-generation hybrid intravascular imaging system, we are entering a new phase focused on U.S. commercialization and delivering meaningful clinical impact."
1
7
162
$CNVI.V $CNVIF #Conavi is thrilled to announce FDA #510k clearance of our next-generation hybrid imaging system and to begin executing on our U.S. commercial launch for H2 2026. As the first co-registered, co-aligned #IVUS and #OCT platform, our system helps give physicians a more complete view of the vessel, streamline workflows, and enhance precision across one of the most common procedures globally. With clinical evidence and guideline support strengthening, this represents a significant opportunity in the rapidly expanding #IntravascularImaging market. Thank you to the #CNVI team, partners, physicians, and investors who made this possible! 🫀🌏 Full Release 🔗 lnkd.in/eHkJgdd7
1
1
1
4
1,111
$CNVI.V $CNVIF CEO @ThomasLooby will be presenting and available for 1-on-1 meetings at the the 2026 Bloom Burton & Co. Healthcare Investor Conference. #Conavi Presentation Details: 📆 Wednesday April 22 🕥 9:30 a.m. ET 📍 Metro Toronto Convention Centre ▶️ Webcast: lnkd.in/er6QQMfi 🔗 More Information: lnkd.in/eDVJWWGY #BBHIC26
3
249
$CNVI $CNVIF On #WorldHealthDay, we join @WHO to #StandWithScience! 🧡🌎 Behind the 4M+ #PCI's performed each year, is a parent, spouse, friend, and a physician turning evidence into action to save lives. #Conavi believes powerful health decisions start with clarity and advance without compromise. This is why we’re combining #IVUS with #OCT to remove potential blind spots with single modality #IntravascularImaging systems. 🩺
1
1
3
1,842